Q
688677
vs
S
Shanghai Composite
Over the past 12 months, Qingdao NovelBeam Technology Co Ltd has outperformed Shanghai Composite, delivering a return of +25% compared to the Shanghai Composite's +14% growth.
Stocks Performance
688677 vs Shanghai Composite
Performance Gap
688677 vs Shanghai Composite
Performance By Year
688677 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Qingdao NovelBeam Technology Co Ltd
Glance View
Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.
